2024-04-24 10:00:42 ET
More on Health Care Select Sector SPDR
- XLV: Fundamentals Don't Support Overweighting Health Care
- XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance
- BofA watched clients retract $2B last week as the S&P dropped
- Tech advances are catalyzing the Health Care sector with improved investor sentiment - SSGA
- Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR
Read the full article on Seeking Alpha
For further details see:
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers